Atlas Trials

Exploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe Dementia

Clinical trial NCT06946511 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06946511
Sponsor
Ruijin Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Dementia
Start date
2025-08-01
Primary completion
2026-01-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.